https://orcid.org/0000-0003-3918-2385
Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lisanne Noordam, Monique T.A. de Beijer, Shanta Mancham, Isabel Vogler, Patrick P.C. Boor, Valeska de Ruiter, Robbie Luijten, Jan N.M. IJzermans, Ugur Sahin, Marco J. Bruno, Dave Sprengers, Sonja I. Buschow & Jaap Kwekkeboom. (2022) Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients. OncoImmunology 11:1.
Read now
Read now
Articles from other publishers (11)
Sreenivasulu Basha, Brady Jin-Smith, Chunbao Sun & Liya Pi. (2023) The SLIT/ROBO Pathway in Liver Fibrosis and Cancer. Biomolecules 13:5, pages 785.
Crossref
Crossref
Yongxue Lv, Liangliang Chang, Jihui Yang, Jia Wen, Yinqi Zhao, Mingxing Zhu, Changyou Wu & Wei Zhao. (2023)
Immunogenicity of peptide‐based vaccine composed of epitopes from
Echinococcus granulosus
rEg
.
P29
. The FASEB Journal 37:4.
Crossref
Crossref
Ying-Zhe Luo & Hong Zhu. (2023) Immunotherapy for advanced or recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 15:3, pages 405-424.
Crossref
Crossref
Deepa S Mandlik, Satish K Mandlik & Heena B Choudhary. (2023) Immunotherapy for hepatocellular carcinoma: Current status and future perspectives. World Journal of Gastroenterology 29:6, pages 1054-1075.
Crossref
Crossref
Disha D. Shah, Bhavarth P. Dave, Parv A. Patel, Mehul R. Chorawala, Vishvas N. Patel, Palak A. Shah & Manish P. Patel. (2023) Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities. Medical Oncology 40:2.
Crossref
Crossref
Iker Malaina, Luis Martínez, Juan Manuel Montoya, Santos Alonso, María Dolores Boyano, Aintzane Asumendi, Rosa Izu, Ana Sanchez-Diez, Goikoane Cancho-Galan & Ildefonso M. de la Fuente. (2023) A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma. Life 13:1, pages 155.
Crossref
Crossref
M. V. Dmitrieva, M. A. Baryshnikovа, O. L. Orlova & V. S. Kosorukov. (2022) Technological aspects of creating neopeptide vaccines. Russian Journal of Biotherapy 21:4, pages 10-21.
Crossref
Crossref
Heng-Tong Han, Wei-Lin Jin & Xun Li. (2022) Mesenchymal stem cells-based therapy in liver diseases. Molecular Biomedicine 3:1.
Crossref
Crossref
Chun-Ye Zhang, Shuai Liu & Ming Yang. (2022) Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy. World Journal of Gastroenterology 28:27, pages 3346-3358.
Crossref
Crossref
Markus W. Löffler, Stefania Gori, Francesco Izzo, Andrea Mayer-Mokler, Paolo A. Ascierto, Alfred Königsrainer, Yuk Ting Ma, Bruno Sangro, Sven Francque, Luisa Vonghia, Alessandro Inno, Antonio Avallone, Jörg Ludwig, Diego Duarte Alcoba, Christian Flohr, Katrin Aslan, Regina Mendrzyk, Heiko Schuster, Marco Borrelli, Danila Valmori, Tanguy Chaumette, Regina Heidenreich, Cécile Gouttefangeas, Greta Forlani, Maria Tagliamonte, Caterina Fusco, Roberta Penta, Mercedes Iñarrairaegui, Ulrike Gnad-Vogt, Carsten Reinhardt, Toni Weinschenk, Roberto S. Accolla, Harpreet Singh-Jasuja, Hans-Georg Rammensee & Luigi Buonaguro. (2022) Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma. Clinical Cancer Research 28:12, pages 2555-2566.
Crossref
Crossref
David Repáraz, Belén Aparicio, Diana Llopiz, Sandra Hervás-Stubbs & Pablo Sarobe. (2022) Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?. International Journal of Molecular Sciences 23:4, pages 2022.
Crossref
Crossref